Membrane Oxygenators Market by Type, Age Group, Application

Description

List of Tables

[184 Pages Report] The Membrane Oxygenators Market size was estimated at USD 615.84 million in 2023 and expected to reach USD 659.81 million in 2024, at a CAGR 6.66% to reach USD 967.62 million by 2030.

The membrane oxygenator devices are critical components in extracorporeal membrane oxygenation (ECMO) systems, which provide prolonged cardiac and respiratory support by oxygenating a patient's blood outside the body. The membrane oxygenators market refers to the space within the medical devices industry focused on designing, manufacturing, and selling membrane oxygenators. Several factors, such as increasing prevalence of respiratory diseases, technological advancements, and an increase in the number of ECMO centers globally influence the growth of the membrane oxygenators market. Additionally, an aging population susceptible to chronic diseases and improvements in healthcare infrastructure have contributed positively to the expansion. Government initiatives to improve access to advanced healthcare treatments provide further growth impetus for the market. However, the high cost of ECMO procedures and associated equipment can restrict market accessibility in resource-constrained settings. Concerns surrounding the complexity of the treatment, the need for specialized training for healthcare providers, and the risk of complications such as bleeding and infection also pose challenges for market growth. Moreover, technological innovations aimed at increasing efficiency and reducing complications associated with ECMO treatment are attracting opportunities in the market. Integrating sensors to monitor oxygenator performance and incorporating smart technologies for real-time data analysis and patient management also has growth potential in upcoming years.

KEY MARKET STATISTICS
Base Year [2023]	USD 615.84 million
Estimated Year [2024]	USD 659.81 million
Forecast Year [2030]	USD 967.62 million
CAGR (%)	6.66%

Type: Increasing preference for flat sheet membrane oxygenators due to low prime volume

Flat sheet membrane oxygenators are a type of gas exchange device used in extracorporeal membrane oxygenation (ECMO) systems. Flat sheet membrane oxygenators employ flat sheet membranes that facilitate the transfer of oxygen into and carbon dioxide out of the blood. Flat sheet membrane oxygenators are often preferred in specific clinical environments due to their low prime volume, which minimizes the amount of blood required to fill the oxygenator, making them suitable for neonatal and pediatric patients. However, hollow fiber membrane oxygenators consist of bundles of microporous hollow fibers through which blood flows externally, and gas exchange occurs across the semipermeable membrane. Hollow fiber membrane oxygenators are widely preferred for adult ECMO due to their efficient gas exchange capabilities and lower resistance compared to flat sheet models.

Application: Diverse applications in cardiac disorders to provide extracorporeal circulation and oxygenation

In the cardiac application segment, membrane oxygenators are critical for patients who require support during open-heart surgery and other cardiovascular procedures. Membrane oxygenators provide extracorporeal circulation and oxygenation of the blood, ensuring vital organs are protected while the heart is temporarily stopped. The performance criteria that determine the preference for a cardiac membrane oxygenator include high gas exchange capacity, low pressure drop, low priming volume, and biocompatibility to minimize the risk of blood clotting and hemolysis. For Extracorporeal Cardiopulmonary Resuscitation (ECPR), membrane oxygenators play a quintessential role in providing life-saving measures for patients in cardiac arrest when conventional CPR is ineffective. ECPR oxygenators must rapidly deliver oxygenation to prevent tissue hypoxia and support hemodynamics until the heart function can be stabilized. Respiratory applications of membrane oxygenators are mainly for patients with severe respiratory failure, unresponsive to conventional mechanical ventilatory support. Membrane oxygenators are tasked with removing CO2 and providing oxygenation over prolonged periods, often in the context of Acute Respiratory Distress Syndrome (ARDS) or for long-term support in chronic respiratory conditions.

Regional Insights

In the Americas, particularly in the United States and Canada, there is a robust demand for membrane oxygenators owing to a well-established healthcare infrastructure and high incidence of cardiovascular and respiratory diseases. Innovations in cardiopulmonary bypass surgery techniques and the rising prevalence of COPD (Chronic Obstructive Pulmonary Disease) further enhance the market in the Americas region. European countries show a deep commitment to patient safety and rigorous adherence to health regulations, leading to the rising adoption of high-quality standards and the implementation of advanced technology compliances. Factors such as an aging population, stringent regulations, and government-funded healthcare systems drive the need for membrane oxygenators in the European region. The Middle East and Africa are gradually emerging markets for membrane oxygenators, influenced by the development of healthcare infrastructure and increased healthcare expenditure by governments, particularly in the Gulf Cooperation Council (GCC) countries. China, India, and Japan have emerged as significant countries in the Asia-Pacific region due to its large population base, increasing healthcare reforms, and investment in healthcare infrastructure. The patent activity in China reflects a focus on cost-effective and scalable manufacturing processes for membrane oxygenators. Japan offers a mature market with emphasis on technology and quality and India is a fast-growing market, with rising prevalence of respiratory and cardiac diseases. However, affordability and accessibility are key drivers in the APAC region, leading to price-sensitive purchasing behavior and a need for cost-effective products.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Membrane Oxygenators Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Membrane Oxygenators Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Membrane Oxygenators Market, highlighting leading vendors and their innovative profiles. These include Alpha Plan GmbH, Braile Biomedica, Chalice Medical Ltd., Cytosorbents Corporation, Elite Lifecare, EUROSETS S.r.l., Fresenius SE & Co KGaA, Gen World Medical Devices, Getinge AB, Harvard Apparatus, Inc., LivaNova PLC, MC3 Cardiopulmonary, Medihub Sciencetec Private Limited, Medtronic PLC, Microport Scientific Corporation, Nipro Corporation, Owgels Group, Senko Medical Instrument Mfg. Co., Ltd., Shandong Wego New Life Medical Devices Co.,Ltd., Terumo Corporation, and Xenios AG by Fresenius Medical Care AG & Co. KGaA.

Market Segmentation & Coverage

This research report categorizes the Membrane Oxygenators Market to forecast the revenues and analyze trends in each of the following sub-markets:

Type
- Flat Sheet Membrane Oxygenators
- Hollow Fiber Membrane Oxygenators

Age Group
- Adults
- Neonates
- Pediatrics

Application
- Cardiac
  - Acute Myocardial Infarction
  - Cardiogenic Shock
  - Decompensated Cardiomyopathy
  - Myocarditis
  - Post-transplant Complications

ECPR
Respiratory
- Acute Respiratory Distress Syndrome
- Pneumonia
- Pulmonary Embolism
- Respiratory Failure

Region
- Americas
  - Argentina
  - Brazil
  - Canada
  - Mexico
  - United States
    - California
    - Florida
    - Illinois
    - New York
    - Ohio
    - Pennsylvania
    - Texas
- Asia-Pacific
  - Australia
  - China
  - India
  - Indonesia
  - Japan
  - Malaysia
  - Philippines
  - Singapore
  - South Korea
  - Taiwan
  - Thailand
  - Vietnam

Europe, Middle East & Africa
- Denmark
- Egypt
- Finland
- France
- Germany
- Israel
- Italy
- Netherlands
- Nigeria
- Norway
- Poland
- Qatar
- Russia
- Saudi Arabia
- South Africa
- Spain
- Sweden
- Switzerland
- Turkey
- United Arab Emirates
- United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.

2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.

3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.

4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.

5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Membrane Oxygenators Market?

2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Membrane Oxygenators Market?

3. What are the technology trends and regulatory frameworks in the Membrane Oxygenators Market?

4. What is the market share of the leading vendors in the Membrane Oxygenators Market?

5. Which modes and strategic moves are suitable for entering the Membrane Oxygenators Market?

Product Code: MRR-3E7F10ED1B0D

1. Preface

1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders

2. Research Methodology

2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

5.1. Market Dynamics
- 5.1.1. Drivers
  - 5.1.1.1. Growing Prevalence of Cardiopulmonary Disorders
  - 5.1.1.2. Increasing Consumer Preference of Minimally Invasive Surgeries
  - 5.1.1.3. Growing Number of Extracorporeal Membrane Oxygenator Centers
- 5.1.2. Restraints
  - 5.1.2.1. Complications Arising from Membrane Oxygenators such as Hemolysis, Infections, Pressure Drop, and Others
  - 5.1.2.2. High Cost Associated with Membrane Oxygenator Devices
- 5.1.3. Opportunities
  - 5.1.3.1. Availability of Technologically Advanced Membrane Oxygenators
  - 5.1.3.2. Several Government Initiatives and Reimbursement Policies
- 5.1.4. Challenges
  - 5.1.4.1. Stringent Regulations Laid Down by the Government and Regulatory Bodies
5.2. Market Segmentation Analysis
- 5.2.1. Type: Increasing preference for flat sheet membrane oxygenators due to low prime volume
- 5.2.2. Application: Diverse applications in cardiac disorders to provide extracorporeal circulation and oxygenation
5.3. Market Trend Analysis
5.4. Cumulative Impact of Russia-Ukraine Conflict
5.5. Cumulative Impact of High Inflation
5.6. Porter's Five Forces Analysis
- 5.6.1. Threat of New Entrants
- 5.6.2. Threat of Substitutes
- 5.6.3. Bargaining Power of Customers
- 5.6.4. Bargaining Power of Suppliers
- 5.6.5. Industry Rivalry
5.7. Value Chain & Critical Path Analysis
5.8. Regulatory Framework Analysis
5.9. Client Customization

6. Membrane Oxygenators Market, by Type

6.1. Introduction
6.2. Flat Sheet Membrane Oxygenators
6.3. Hollow Fiber Membrane Oxygenators

7. Membrane Oxygenators Market, by Age Group

7.1. Introduction
7.2. Adults
7.3. Neonates
7.4. Pediatrics

8. Membrane Oxygenators Market, by Application

8.1. Introduction
8.2. Cardiac
8.3. ECPR
8.4. Respiratory

9. Americas Membrane Oxygenators Market

9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States

10. Asia-Pacific Membrane Oxygenators Market

10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
10.13. Vietnam

11. Europe, Middle East & Africa Membrane Oxygenators Market

11.1. Introduction
11.2. Denmark
11.3. Egypt
11.4. Finland
11.5. France
11.6. Germany
11.7. Israel
11.8. Italy
11.9. Netherlands
11.10. Nigeria
11.11. Norway
11.12. Poland
11.13. Qatar
11.14. Russia
11.15. Saudi Arabia
11.16. South Africa
11.17. Spain
11.18. Sweden
11.19. Switzerland
11.20. Turkey
11.21. United Arab Emirates
11.22. United Kingdom

12. Competitive Landscape

12.1. Market Share Analysis, 2023
12.2. FPNV Positioning Matrix, 2023
12.3. Competitive Scenario Analysis
- 12.3.1. USD 10 Million Grant To Boost Cardiac Arrest Care In Minnesota
- 12.3.2. Debut Domestic Blood Oxygenator to Be Produced in Moscow
- 12.3.3. Inspira Technologies is Developing the VORTX Blood Oxygenator, a Unique Technology for Saturating Blood With Oxygen and Removing Carbon Dioxide

13. Competitive Portfolio

13.1. Key Company Profiles
13.2. Key Product Portfolio